Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study shows lower light pollution during COVID-19 lockdown in Granada

Study shows lower light pollution during COVID-19 lockdown in Granada

Early interferon therapy may mitigate COVID-19 severity

Early interferon therapy may mitigate COVID-19 severity

Early use of existing treatment helps save hospitalized COVID-19 patients

Early use of existing treatment helps save hospitalized COVID-19 patients

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

Specific SARS-CoV-2 genomic variations are associated with higher COVID-19 deaths

SARS-CoV-2 likely circulating in China as early as mid-October 2019

SARS-CoV-2 likely circulating in China as early as mid-October 2019

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Researchers discover close SARS-CoV-2-relative in animal hosts outside China

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

SARS-CoV-2 spike protein antibodies can persist up to 200 days after symptom onset

Is COVID-19 severity mediated by higher antibody response?

Is COVID-19 severity mediated by higher antibody response?

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

A review of Traditional Chinese herbal medicine in management of COVID-19

A review of Traditional Chinese herbal medicine in management of COVID-19

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Mild COVID-19 disease may trigger long-term immunity

Mild COVID-19 disease may trigger long-term immunity

Vaping does not appear to pose any significant additional risk of SARS-CoV-2 transmission

Vaping does not appear to pose any significant additional risk of SARS-CoV-2 transmission

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

Digital warm-start CRISPR assay enables sensitive quantitative detection of SARS-CoV-2 in clinical samples

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.